- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00663156
A Prospective Study of Autologous Fat Grafting for Breast Augmentation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The current standard for breast augmentation involves placement of an implant. Although implants are safe, they are foreign bodies and thus have inherent risks including infection, failure, malposition, etc. In order to avoid the inherent risks of an implanted device, some surgeons and patients have elected to proceed with breast augmentation from autologous tissue. Early reports of autologous fat transplantation to the breasts were successful, but increases in breast volume were modest (Bircoll, 1987). There were also hypothetical concerns about changes in the breast tissue that would interfere with mammographic screening for breast cancer.
Spear et al (2005) performed autologous fat transplantation to reconstructed breasts in 37 patients with 2-dimensional photographic evidence of improved breast shape and volume suggesting that this technique can be effectively performed. However, these patients had all received mastectomies so mammographic screening was not indicated. Coleman and Saboeiro (2007) performed autologous fat transplantation to the breasts in 17 patients. Fifteen of the 17 patients received post-operative mammograms, 7 (47%) of which were abnormal. However, none of these abnormal findings interfered with cancer screening. Furthermore, 2 patients in the study did develop breast cancer which was successfully detected by mammography. Other studies have confirmed the ability to differentiate benign from malignant findings on mammogram after autologous fat transplantation. Pulagam et al (2006) reported long term (10 and 8 year) findings on 2 patients that underwent autologous fat transplantation to the breasts. Mammography and ultrasound were used to differentiate benign from malignant appearing calcifications. Some authors have speculated that autologous fat transplantation to the breast would lead to mammographic changes similar to routine breast procedures such as breast reduction and mastopexy (Coleman and Saboeiro, 2007).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- Georgetown University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 20-50 years old
- willing to have mammogram, MRI, and photographs
- willing to follow study requirements and sign informed consent
- no previous breast surgeries
- must reside within 50 miles of the Washington, D.C. Metropolitan area
Exclusion Criteria:
- pregnant or nursing
- existing breast cancer
- advanced fibrocystic disease
- protease inhibitors
- any condition leading to surgical risk
- any disease known to affect wound healing
- abscess or infection in the body
- incompatible psychological factors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: subject
10 subjects receiving breast augmentation with fat grafting
|
Autologous fat will be harvested from the body (typically the abdomen or thighs) using syringe aspiration techniques and then infiltrated into the subcutaneous tissue around the breast as well as between the breast and the underlying musculature using blunt cannulas.
These procedures will be done in an outpatient surgery setting in the Georgetown University Hospital under general anesthesia and sterile conditions.
Other Names:
|
|
Other: control
10 control will have breast augmentation using breast implants
|
patients will have breast augmentation using implants
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effectiveness will be evaluated by comparing breast volume pre-operatively and at 1 year post-operatively using 3-dimensional picture imaging to obtain objective volume measurements.
Time Frame: One year post-op
|
One year post-op
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Patients will be evaluated by mammogram, MRI, and 3-D photography to monitor for breast tissue abnormalities and measure increase in volume
Time Frame: one year
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Scott L Spear, MD, Georgetown University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 4359-617
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Augmentation
-
Sientra, Inc.TerminatedBreast Augmentation | Breast Revision-AugmentationUnited States
-
Allergan MedicalCompletedBreast Augmentation | Breast Reconstruction | Revision of Augmentation or ReconstructionUnited States
-
Allergan MedicalCompletedBreast Augmentation | Breast Reconstruction | Revision of Augmentation or ReconstructionUnited States
-
Establishment LabsEnrolling by invitationBreast Augmentation | Mammaplasty | Tissue Preservation | Breast Augmentation and Breast ReconstructionCosta Rica
-
Mentor Worldwide, LLCActive, not recruitingPrimary Breast Augmentation | Primary Breast Reconstruction | Revision Breast Augmentation | Revision Breast ReconstructionUnited States
-
AllerganCompletedBreast AugmentationGermany, Sweden, United Kingdom
-
AllerganCompletedBreast AugmentationSweden
-
Ideal Implant IncorporatedCompleted
-
Sientra, Inc.Active, not recruitingBreast Augmentation | Breast Reconstruction | Breast RevisionUnited States
Clinical Trials on Liposuction, fat grafting
-
Ahmed Mohamed AbouzaidCompleted
-
University College, LondonCompletedDiabetes Mellitus Foot UlcerUnited Kingdom
-
Melanie Salerno, RNLifespanUnknown
-
Lawson Health Research InstituteNot yet recruitingBreast Asymmetry | Fat Atrophy
-
Mayo ClinicEnrolling by invitationBreast Reconstruction | Radiation Dermatitis | Radiation Fibrosis | Fat GraftingUnited States
-
Mayo ClinicWithdrawnBreast CancerUnited States
-
University of PittsburghUnited States Department of DefenseTerminatedCraniofacial InjuriesUnited States
-
Peking Union Medical CollegeUnknownBreast Cancer LymphedemaChina
-
University of Texas Southwestern Medical CenterCompletedAcne Scars - Mixed Atrophic and Hypertrophic | AcneUnited States
-
University of PittsburghCompleted